Company intelligence / Profile preview

nference

Cambridge, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

nference is an active technology-driven healthcare company specializing in artificial intelligence applied to vast multimodal healthcare data. Its main platform, nferX, is used by major biopharmaceutical companies and institutions to synthesize biomedical knowledge, enable target discovery, biomarker identification, real-world outcomes research, and support drug discovery and development. nference does not itself develop therapeutic products but enables such research for clients and collaborators through its robust AI platform and access to the largest labeled EMR dataset in healthcare[2][3][4][5].

Industry: Drug Discovery Services

Partnerships

Mayo ClinicDuke University Health SystemValo HealthAvadelBeiGene

Beyond the preview

Go deeper on nference.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on nference.

Explore the full profile